INVO Fertility, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. (Nasdaq: IVF) on September 22, 2025. The filing discloses the entry into a material definitive agreement regarding the company's existing debt obligations with Decathlon Alpha V LP.
Key Financial Metrics and Debt
The filing focuses on a Revenue Loan and Security Agreement originally executed on September 29, 2023, with a gross principal amount of $1,500,000. The filing does not provide current revenue, profit, cash flow, or liquidity metrics. The primary financial impact disclosed is an increase in the cost of debt and a modification of the repayment schedule.
Material Changes and Agreement Amendments
The company entered into a "Restated Third Amendment" to its Loan Agreement on September 22, 2025. Key changes include:
- Interest Rate Increase: Because the company failed to raise $1,000,000 in equity investment by the November 30, 2024 deadline, the "Minimum Interest" multiples were increased by 0.15.
- Repayment Schedule: Building on a prior amendment from August 13, 2025, the monthly payment under the Loan Agreement was increased by $20,000.
- Default Waiver: The Lender waived an event of default related to a judgment entry pursuant to a Term Sheet with Dr. Pritts and the Pritts Trust.
- Corporate Name Change: The Lender consented to the company's name change to INVO Fertility, Inc.
- Fees: The company agreed to reimburse the Lender approximately $17,500 for fees and expenses associated with the Third Amendment.
Outlook, Risks, and Contingencies
The filing highlights significant liquidity and financing risks. The company previously agreed (in the Second Amendment dated October 11, 2024) to retain an investment banker to pursue financing or a sale if it failed to meet certain liquidity covenants. The failure to secure the $1,000,000 equity investment triggered the interest rate penalty, indicating ongoing challenges in raising capital.
Investor Verification Checklist
- Verify the current outstanding principal balance of the $1,500,000 Decathlon loan.
- Confirm the specific calculation of the new "Minimum Interest" multiple and its impact on total debt service.
- Review the company's latest 10-Q or 10-K to assess current liquidity levels against the covenants mentioned in the Second Amendment.
- Investigate the status of the "judgment" with Dr. Pritts that was waived by the Lender.
- Check for any subsequent filings regarding the retention of an investment banker or progress on a potential sale/financing.